Tejnaksh Healthcare Board of Directors
Get the latest insights into the leadership at Tejnaksh Healthcare. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Dr. Ashish Vishwas Rawandale | Managing Director |
| Mr. Sanjay Bhikajirao Khatal | Non Executive Director |
| Dr.(Ms.) Preeti Ashish Rawandale | Non Executive Woman Director |
| Mr. Kiran Madhavrao Pawar | Independent Director |
| Mr. Vikramsinh Satish Khatal Patil | Independent Director |
| Mr. Suhas Thorat | Independent Director |
Tejnaksh Healthcare Share price
TEJNAKSH
16.68
0.22 (1.34%)Last updated on 21 Nov, 2025 | 15:17 IST
BUYSELL
Today's High
16.85
Today's Low
16.35
52 Week Low
16.20
52 Week High
29.50
The current prices are delayed, login to your account for live prices
LoginTejnaksh Healthcare FAQs
The board at Tejnaksh Healthcare consists of experienced professionals, including Dr. Ashish Vishwas Rawandale , Mr. Sanjay Bhikajirao Khatal , and others, overseeing the company’s strategic and corporate governance.
Directors at Tejnaksh Healthcare are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Dr. Ashish Vishwas Rawandale is the current chairman at Tejnaksh Healthcare.
Executive directors at Tejnaksh Healthcare are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Tejnaksh Healthcare adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Tejnaksh Healthcare, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.